is microdosing glp-1 covered by insurance change impacts millions of Americans: What to know, how to tell if you're Microdosing GLP-1: Understanding the Risks

For guidance on transitioning between these peptides , sequential use is the standard approach

The growing demand for GLP-1 injections reflects a wider shift

The FDA position In January of a recent evaluation cycle, the FDA conducted a preliminary assessment of GLP-1 receptor agonists and psychiatric side effects

Minimal Lifestyle Disruption : Unlike restrictive diets or invasive surgery, GLP-1 therapy allows for gradual, sustainable weight loss without the need for drastic lifestyle changes

Tirzepatide also appears to offer improvement in hepatic steatosis (Gastadelli et al, 2022)

Zhao H, Zhang J, Cheng X, Nie X, He B (2023) Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment